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Objectives. The purpose of this study was to define the value of
exercise echocardiography as an independent predictor of cardiac
events in women with known or suspected coronary artery disease
(CAD), incremental to the data provided by clinical evaluation
and exercise testing.
Background. Exercise echocardiography is more accurate than
exercise electrocardiography for the identification of CAD in
women. However, the prognostic implications of exercise echocar-
diography, especially relative to exercise electrocardiography, are
undefined.
Methods. Symptom-limited exercise echocardiography was per-
formed in 549 consecutive women between 1989 and 1993. Echo-
cardiography and electrocardiography were performed before and
after treadmill exercise; an abnormal result on exercise electro-
cardiography was defined by ST segment depression >0.1 mV,
ischemia by exercise echocardiography as a new or worse wall
motion abnormality after exercise and scar by akinesia or dyski-
nesia at rest. After exclusion of six patients with uninterpretable
studies (1%) and 35 (6%) lost to follow-up, 508 women (mean
[6SD] age 55 6 11 years) were followed up for 41 6 10 months for
cardiac-related death, infarction or late revascularization.
Results. The group attained 92 6 10% of age-predicted maximal
heart rate, with an exercise capacity of 7 6 2 metabolic equiva-
lents. Of 420 women with an interpretable electrocardiogram,
significant ST segment changes were present in 68 (16%). Results
of exercise echocardiography were normal in 413 (81%) women,
positive for ischemia in 66 (13%) and scar only in 29 (6%). No
events occurred in 444 patients (89%), and 19 underwent primary
revascularization (within 3 months of exercise test). Cardiac
events occurred in 36 women (7%), including 17 who died of
cardiac causes and 19 who had a myocardial infarction or
required late revascularization for progressive symptoms. On
univariate analysis, the variables associated with cardiac mortal-
ity and total cardiac events were a history of CAD, diabetes, left
ventricular hypertrophy, exercise capacity and echocardiographic
evidence of myocardial ischemia and infarction. A Cox propor-
tional hazards model showed the independent predictors of out-
come to be known CAD (odds ratio [OR] 6.6, 95% confidence
interval [CI] 3.2 to 13.7, p < 0.00001) and echocardiographic
ischemia (OR 4.3, 95% CI 2.1 to 8.7, p < 0.0001). The prognostic
value of exercise echocardiography incremental to clinical and
exercise variables was demonstrated using sequential Cox models.
Conclusions. In this large cohort of women, exercise echocar-
diography provided key prognostic information incremental to
clinical and exercise testing data.
(J Am Coll Cardiol 1997;30:414–20)
©1997 by the American College of Cardiology
Coronary artery disease (CAD) is the leading cause of death in
women in the United States (1). However, although the
prognosis of patients with known CAD is worse in women than
men, most women presenting with chest pain syndromes follow
a benign course (2). The challenge for the physician is to
identify the minority of women at high risk for cardiac events
in whom outcome might be improved by further intervention.
Historically, exercise electrocardiography has been the best
studied and most commonly used noninvasive test to establish
prognosis (3–6). However, the accuracy of this test for the
diagnosis of CAD in women has been questioned, with studies
showing a spectrum of accuracy (7–14). Limited data suggest
that the use of exercise testing is a better predictor of cardiac
events in men than in women (15). Exercise echocardiography
appears to be more accurate than exercise electrocardiography
for the diagnosis of CAD in women (16–18). The prognostic
utility of exercise echocardiography has been evaluated in
mixed (largely male) groups, but the ability of this test to
predict outcomes in women has not been evaluated. The
purpose of the present study was to determine the independent
ability of exercise echocardiography to predict cardiac events
in a large heterogeneous group of women with known or
suspected CAD and to identify whether these data were
incremental to clinical predictors of outcome.
Methods
Patient selection. Five hundred forty-nine women with
known or suspected CAD underwent exercise echocardiogra-
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phy between August 1989 and October 1993 for the first time
at our institution. The only studies excluded were those that
were uninterpretable because of inadequate image quality
(n 5 6).
Clinical evaluation. Of the remaining 543 women (mean
[6SD] age 55 6 11 years), 95 (17%) had known CAD, defined
by a history of myocardial infarction, revascularization or
angiographically defined stenosis (.50% diameter) of a major
vessel. In patients without a previous history of CAD, a
coronary risk profile derived by the Framingham Heart Study
(19) was calculated from the lipid profile, blood pressure,
smoking status and diabetes history.
Exercise testing. All patients underwent a symptom-
limited treadmill exercise test, using a protocol appropriate for
each individual patient (either Bruce, modified Bruce or
Naughton). Heart rate and blood pressure were measured and
standard 12-lead electrocardiograms (ECGs) were recorded at
rest, during each stage of exercise and during recovery. ST
segment deviation was measured 0.08 s after the J point and
was considered significant if there was $1 mm of horizontal or
downgoing ST segment depression in two or more contiguous
leads. ST segment changes in the presence of left bundle
branch block, digoxin therapy or left ventricular (LV) hyper-
trophy were considered nondiagnostic. Maximal exercise ca-
pacity was recorded in estimated metabolic equivalents
(METS). The impact of exercise capacity on outcome was
analyzed as a continuous variable as well as on the basis of
failure to attain .6 METS.
A treadmill score was calculated according to the formula
described by Mark et al. (4): Treadmill score 5 Duration of
exercise (Bruce protocol) 2 (5 3 Maximal net ST segment
deviation [mm]) 2 (4 3 Treadmill angina index). The tread-
mill angina index was 0 if there was no angina during exercise,
1 if there was nonlimiting angina and 2 if there was angina that
caused termination of exercise. A maximal heart rate response
was considered to be $85% of the age-predicted maximal
heart rate; however, patients who did not achieve this rate were
also included in the analysis.
Exercise echocardiography. Two-dimensional echocardi-
ography was performed at rest, in the left lateral decubitus
position, immediately before exercise, using standard ultra-
sound equipment. Images were obtained in the parasternal
long- and short-axis and the apical two- and four-chamber
views. All images were recorded on 0.5-in. VHS tape and
digitized on-line using PreVue or ImageVue systems (Nova
MicroSonics). Postexercise images were obtained, usually
within 1 min of completion of exercise, using the same views.
All studies were reviewed by an experienced observer. Isch-
emia was defined by new or worsening regional wall motion
abnormalities on exercise. Infarction was defined by akinesia or
dyskinesia of a segment at rest.
Follow-up. Follow-up was performed by review of the
patient’s medical record or by telephone contact 41 6 10
months after exercise echocardiography in 508 women (94%).
The measured primary end points were cardiac-related death,
myocardial infarction and late myocardial revascularization
(defined as coronary artery bypass graft surgery [CABG] or
percutaneous transluminal coronary angioplasty [PTCA] .3
months after the test), and the date of contact or the occur-
rence of an end point was recorded. Non–cardiac-related death
was defined as death not due to myocardial infarction, cardio-
genic shock or cardiac arrhythmia. Primary revascularization
was defined as any PTCA or CABG procedure that occurred
,3 months after the exercise echocardiogram. Patients were
censored from follow-up at the time of non–cardiac-related
death or primary revascularization—the latter step was aimed
at reduction of posttest referral bias.
Statistical analysis. Descriptive statistics were generated
using percentages and 95% confidence intervals (CIs) for
discrete variables and mean value 6 SD for continuous
variables. Discrete variables were compared using chi-square
analysis, and continuous variables were compared using anal-
ysis of variance; differences in outcomes were reported as odds
ratios (ORs). Cardiac survival was expressed using Kaplan-
Meier survival curves, which were compared by log-rank
chi-square analysis. Multivariable analysis was performed using
a Cox proportional hazards model.
The prognostic value of exercise echocardiography incre-
mental to clinical and exercise testing data was assessed using
sequential Cox models, whereby additional information was
added to the models in the same sequence as in clinical
practice. Thus, after defining the global chi-square of the
clinical variables, the independent predictors from this model
were added to exercise testing variables to create a second
model. These predictors were then added to the results of
echocardiography to create a third model. All patients partic-
ipated in each model. The incremental benefit was defined by
comparison of the global chi-square for each model. All
statistics were performed using the SPSS for Windows statis-
tical package.
Results
Clinical characteristics. Table 1 contrasts the characteris-
tics of the 508 women who were followed-up over 41 6 10
months with 35 women (6%) who were lost to follow-up. The
latter group were at somewhat lower risk than the study group
because of younger age and greater exercise capacity. The
study group was predominantly middle-aged (average 56 6 11
years), with a significant prevalence of coronary disease risk
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CAD 5 coronary artery disease
CI 5 confidence interval
ECG 5 electrocardiogram, electrocardiographic
LV 5 left ventricular
METS 5 metabolic equivalents
OR 5 odds ratio
PTCA 5 percutaneous transluminal coronary angioplasty
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factors. The diagnosis of CAD was known in 92 women (18%).
Of the 416 women without a history of CAD, the 10 year
cardiac risk, based on the Framingham coronary risk profile,
averaged 8 6 5% (range 0% to 38%).
Exercise testing. Most patients exercised adequately, to a
mean workload of 7 6 2 METS and 92 6 10% of maximal
predicted heart rate. However, 100 women (20%) exercised
submaximally (,85% of maximal heart rate), and the rate–
pressure product ranged from 10.5 to 45.1 3 103 beats/min 3
mm Hg (average 27.7 6 5.2 3 103 beats/min 3 mm Hg).
Ninety-nine women (19%) developed angina during the exer-
cise test, which was nonlimiting in 66 and severe in the other
33.
The exercise ECG was nondiagnostic in 88 women (17%)
because of baseline abnormalities. Of the remaining 420
women, 68 (16%) had significant ST segment changes on
exercise. The average treadmill score was 3 6 4 (range 223 to
21), and 256 women (50%) had a score $5, which placed them
in a low risk category for cardiac events. Only 15 women (3%)
were characterized as high risk on the basis of their treadmill
score.
Exercise echocardiography. Results of exercise echocardi-
ography were abnormal in 95 women (19%). A pattern con-
sistent with infarction (a wall motion abnormality at rest
without exercise-induced abnormalities) was present in 29
women. Ischemia (evidenced by a normal baseline study results
and an exercise-induced wall motion abnormality) was present
in 42 women. In the remaining 24 women, a wall motion
abnormality was present at rest and a new one developed with
exercise, consistent with ischemia in the setting of a previous
infarction. Of the 95 women with abnormal results on exercise
echocardiography, 56 (59%) had a history of CAD. Only 36 of
the 413 patients (9%) with normal exercise echocardiographic
results had a previous history of CAD.
Outcomes. No events occurred during follow-up in 444
women (87%). Cardiac-related death occurred in 17 women
(3%), and myocardial infarction or late revascularization oc-
curred in 19 (4%). Patients having a revascularization proce-
dure within 3 months of the exercise test (n 5 19 [4%]) or
dying of noncardiac causes (n 5 9 [2%]) were censored at the
time of these events. Non–cardiac-related deaths were due to
malignancy in six patients, chronic pulmonary disease in one,
renal failure in one and noncardiac complications of surgical
intervention in one.
Univariate correlation of outcomes and clinical and exer-
cise variables. Table 2 summarizes the correlation between
clinical variables and cardiac-related events. Both cardiac
mortality and total cardiac events were associated with a
previous history of CAD, diabetes and ECG evidence of
myocardial infarction or LV hypertrophy. Ninety-five patients
had a previous history of CAD, and after exclusion of 15 with
primary revascularization or non–cardiac-related death, 23 of
the remaining patients (30%) with known CAD had a cardiac-
related event during follow-up compared with only 13 (3%) of
403 patients without a history of CAD who had an event. After
exclusion of 5 patients who underwent primary revasculariza-
tion, a cardiac event occurred in 10 (21%) of 48 patients with
versus only 26 (6%) of 432 without diabetes.
Of the 68 women who had significant ST segment changes
on exercise, 8 underwent primary revascularization or died of
noncardiac causes. Cardiac events occurred in 9 (15%) of the
remaining 60 women with ST segment changes during the
follow-up period compared with only 18 (5%) of 337 without
ECG changes (OR 3.1, p 5 0.01). However, ST segment
changes were not significantly correlated with cardiac-related
death.






(n 5 35) p Value
Age (yr) 56 6 11 46 6 13 ,0.0001
Known CAD 92 (18%) 3 (9%) 0.17*
Medications
Ca blockers 116 (23%) 9 (26%)
Beta-blockers 78 (15%) 5 (14%) 0.06*
Nitrates 45 (9%) 2 (6%)
Hypertension 197 (39%) 12 (34%) 0.6*
Diabetes 53 (10%) 4 (11%) 0.8*
Smoker 81 (16%) 4 (11%) 0.6*
MI (by ECG) 36 (7%) 3 (9%) 0.73*
LVH (by ECG) 25 (5%) 5 (14%) 0.03
Exercise cap (METS) 7 6 2 8 6 2 0.0004
HR (% MPHR) 92 6 10% 92 6 10% .0.9*
RPP (beats/min 3 mm Hg) 27,000 6 5,200 28,400 6 5,100 ,0.0001
Sign ST changes 68 (13%) 3 (9%) 0.60*
Treadmill score 3 6 4 5 6 3 ,0.0001
Ischemia by ExE 66 (13%) 4 (11%) .0.95*
*Not significant. Data presented are mean value 6 SD or number (%) of
patients. Ca 5 calcium; CAD 5 coronary artery disease; cap 5 capacity; ECG 5
electrocardiogram; ExE 5 exercise echocardiography; HR 5 heart rate; LVH 5
left ventricular hypertrophy; METS 5 metabolic equivalents; MI 5 myocardial
infarction; %MPHR 5 percent of maximal age-predicted heart rate; RPP 5
rate–pressure product; Sign 5 significant.
Table 2. Univariate Correlates of Cardiac Outcome With Clinical,
Exercise and Echocardiographic Findings
Any Cardiac Event Cardiac Death
OR (95% CI) p Value OR (95% CI) p Value
Hx of CAD 12.8 (5.8–28.5) ,0.0001 8.4 (2.8–25.6) ,0.0001
Hypertension 0.73 (0.4–1.5) 0.37* 1.1 (0.4–3.4) 0.84*
Diabetes 4.1 (1.7–9.8) 0.0002 5.5 (1.7–17.1) 0.004
Smoker 1.6 (0.6–3.8) 0.27* 2.3 (0.7–7.3) 0.16*
MI (by ECG) 4.0 (1.5–10.9) 0.006 4.8 (1.2–17.2) 0.02
LVH (by ECG) 3.4 (0.9–11.6) 0.05 5.6 (1.2–23.9) 0.03
Sign ST changes 3.1 (1.2–7.9) 0.01 1.6 (0.3–8.8) 0.63*
METS ,6 3.1 (1.5–6.4) 0.001 3.3 (1.1–9.9) 0.016
Treadmill score ,5 3.0 (1.4–6.9) 0.003 2.7 (0.9–8.8) 0.08*
Ischemia by ExE 9.8 (4.4–22) ,0.0001 13.6 (4.5–42) ,0.0001
Infarction by ExE 8.5 (3.7–19) ,0.0001 4.4 (1.3–14) 0.015
*Not significant. CI 5 confidence interval; Hx 5 history; OR 5 odds ratio;
other abbreviations as in Table 1.
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The influence of exercise capacity on outcome was analyzed
by classifying the study cohort into two subgroups: women who
achieved $6 METS (n 5 343) and those who achieved ,6
METS (n 5 165). There were 16 cardiac events (5%) in the
group that achieved $6 METS and 20 primary events (13%) in
those who achieved ,6 METS (OR 3.5, p 5 0.001). Exercise
capacity was also associated with cardiac-related death (Table 2).
The treadmill score was associated with cardiac events but not
with cardiac-related death in women.
The association of echocardiographic evidence of ischemia
and infarction with cardiac events in women is summarized in
Figure 1. Cardiac events occurred in 17 (31%) of 54 women
with echocardiographic evidence of ischemia compared with 19
(4%) of 426 without ischemia (OR 9.8, 95% CI 4.4 to 21.9, p ,
0.00001). The event rate of women with echocardiographic
evidence of infarction was 31% and only 5% in the remainder
(OR 8.5, 95% CI 3.7 to 19.4, p , 0.00001).
The data provided by electrocardiography and echocardi-
ography are complementary. The outcomes associated with
combinations of these results are illustrated in Figure 2.
Women who had no ischemia by either modality (n 5 328) had
a 96% event-free survival rate at 30 months, whereas those
who had ischemia by both (n 5 16) had only a 55% event-free
survival rate. Women with conflicting ECG and echocardio-
graphic results had event rates intermediate between these
extremes, but women with positive exercise echocardiographic
and negative ECG findings (n 5 27) had a lower event-free
survival rate (73% at 30 months) than those without echocar-
diographic evidence of ischemia but with ST segment changes
(n 5 52 [91% event-free survival rate at 30 months]).
Figure 1. Event-free survival of patients with normal
results on exercise echocardiograms, ischemia, infarc-
tion and ischemia with infarction.
Figure 2. Event-free survival according to the
presence (1) or absence (2) of ischemia by
exercise echocardiography (ExE) or exercise
electrocardiography (ExECG).
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Multivariate correlation of outcomes and clinical and
exercise variables. The number of variables that could be
incorporated into a multivariate model was limited by the
occurrence of cardiac events in only 36 women. Thus, a Cox
proportional hazards model was based on the relation between
outcome and past cardiac history, diabetes, exercise capacity
and exercise echocardiographic findings. Of these variables,
only a past cardiac history (OR 6.6, 95% CI 3.2 to 13.7, p ,
0.00001) and echocardiographic evidence of ischemia (OR 4.3,
95% CI 2.1 to 8.7, p 5 0.0001) were independent predictors of
outcome.
Incremental value of exercise echocardiography. A se-
quence of Cox proportional hazard models were constructed,
in which the number of patients in each model was the same,
to assess the prognostic value of exercise echocardiography
incremental to other clinical and exercise variables. The initial
model, based on clinical variables, revealed a previous history
of CAD (OR 10.2, 95% CI 5.2 to 20.1, p , 0.0001) to be the
only independent predictor of future cardiac events. In the
second (clinical plus exercise) model, cardiac history was
combined with cardiac workload, ST segment change and
treadmill score. The independent predictors were a previous
history of CAD and the treadmill score (OR 0.94, 95% CI 0.90
to 0.98, p 5 0.004). In the third model, the latter two variables
were combined with evidence of ischemia or infarction at
exercise echocardiography. The independent predictors were a
previous history of CAD and the presence of echocardio-
graphic ischemia (OR 4.3, 95% CI 2.1 to 8.7, p 5 0.0001). The
incremental value of each step in the prediction of cardiac
events is depicted by the global chi-square of the clinical,
exercise and echocardiographic models in Fig. 3.
Because a known history of CAD was such a powerful
predictor for future cardiac-related events in our cohort,
patients were classified on the basis of the presence or absence
of known CAD. The sequential models were reapplied to these
subgroups (Fig. 4). In women without previous CAD, clinical
variables that were significantly associated with future cardiac
outcomes were diabetes (OR 4.3, 95% CI 1.2 to 15.5, p 5 0.03)
and ECG evidence of LV hypertrophy (OR 6.9, 95% CI 1.5 to
31.7, p 5 0.01). The only exercise variable that predicted on
adverse outcome was the treadmill score (OR 0.89, 95% CI
0.83 to 0.97, p 5 0.004). When these features were combined
with the echocardiographic data in the third model, the
presence of ischemia by exercise echocardiography (OR 5.4,
95% CI 1.5 to 19.6, p 5 0.01) added incremental prognostic
data.
In women with a history of CAD, there were no other
clinical predictors of adverse events. In the model that in-
cluded exercise variables, only maximal rate–pressure product
had a borderline significant predictive value (p 5 0.05), but
treadmill score and ECG ischemia were not predictive of
adverse cardiac events. The presence of ischemia by exercise
echocardiography was the only predictor of cardiac events in
the patients with known CAD (OR 3.5, 95% CI 1.5 to 8.1, p 5
0.003).
Comparison of predictive value of exercise testing and
exercise echocardiography. Of the exercise variables, the best
univariate predictor of cardiac events was exercise capacity ,6
METS (Table 2). To further assess the incremental benefit of
echocardiographic imaging during the exercise test, the pa-
tients were classified into low and high risk groups on the basis
of their exercise capacity, and then these subgroups were
further stratified according to their echocardiographic results.
Of 165 patients in the high risk subgroup based on an exercise
capacity ,6 METS, 35 had echocardiographic ischemia. The
event rate was 41% in this subgroup, with concordant high risk
test results. Exercise echocardiography showed no ischemia in
130 patients who exercised to ,6 METS, and the event rate
was 7% in this subgroup. There were 343 patients who
exercised to $6 METS, and 312 of these had no ischemia; the
event rate was 4% in this subgroup, with concordant low risk
test results. The remaining 31 patients exercised to $6 METS
and had ischemia, with an event rate of 20%. Thus, 161
patients had discordant risk stratification based on their exer-
cise capacity and ischemia. Sixteen people in this group had
primary revascularization or non-cardiac-related death. Of the
Figure 3. Incremental value of exercise testing (ExECG) and exercise
echocardiography (ExE) to clinical data (Clin), illustrated by the global
chi-square of sequential Cox models incorporating clinical, exercise
testing and echocardiographic data.
Figure 4. Subanalysis to examine the incremental value of exercise
testing (ExECG) and exercise echocardiography (ExE) to clinical data
(Clin) in patients with (gray bar) and without (solid bars) a history of
known CAD.
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remaining 145 people, the exercise echocardiogram correctly
predicted the outcome in 117, and exercise capacity predicted
the outcome in 28. Therefore, the sum prognostic benefit for
echocardiographic compared to exercise capacity in this study
was 85 patients correctly classified into an appropriate risk
group. After exclusion of the primary revascularization and
patients who died of noncardiac causes the total cohort is 480
women, and of this group, 85 (18%) would be better risk
stratified with exercise echocardiography than exercise capac-
ity alone.
Discussion
In this study, the detection of exercise-induced wall motion
abnormalities was an independent predictor of cardiac events
in 508 women followed up for 41 6 10 months after exercise
echocardiography. Evidence of ischemia by echocardiography
was a better predictor of future cardiac events than exercise
capacity or ST segment changes. The information provided by
exercise echocardiography was incremental to that provided by
clinical and exercise ECG variables, both in the overall study
cohort and in subgroups with and without a previous history of
CAD.
Diagnosis of CAD in women. The reported accuracy of the
ST segment response for the diagnosis of CAD in women has
been variable. A large series, obtained from the Coronary
Artery Surgery Study (14), found no gender differences in the
false positive rate. However, a number of smaller studies
(9–13) have identified either lower sensitivity or specificity in
women. The sensitivity of exercise testing may be compromised
by a number of factors, including lower exercise capacity.
Premenopausal women have a lower pretest probability of
CAD than men (20), which poses a problem for any noninva-
sive approaches to the diagnosis of CAD. Moreover, various
non-Bayesian factors influence the diagnostic performance of
the tests, including mitral valve prolapse and syndrome X (7).
Bayesian factors may compromise the accuracy of myocar-
dial perfusion scintigraphy. Anterior wall image artifacts due
to breast attenuation (21) may cause reduced specificity and
may be avoided by judicious interpretation of transaxial im-
ages. Newer technologies, such as attenuation correction and
use of technetium isotopes (22), which enable the recognition
of normal function in an apparent perfusion defect, may also
reduce false positive results. However, the sensitivity of myo-
cardial perfusion imaging may be lower in women than men
(23). Other non-Bayesian factors that may influence the sen-
sitivity of this test include the smaller size of the female heart,
the greater prevalence of mild CAD and the performance of
submaximal exercise in women.
Exercise echocardiography is an accurate and cost-efficient
test for the diagnosis of CAD in women (16–18). Even after
the exclusion of patients influenced by referral bias, the
specificity of exercise echocardiography exceeds that of ST
segment evaluation alone (18). However, the sensitivity of this
technique is less than that in mixed populations, which prob-
ably reflects the performance of submaximal exercise, as
discussed earlier. The use of pharmacologic stress testing may
be a means of circumventing this limitation (24).
Prognostic evaluation of known or suspected CAD in
women. Few data have addressed gender-based differences in
the risk stratification of CAD. In the single published study of
the prognostic significance of exercise testing according to
gender (15), exercise testing was helpful in both men and
women for the assessment of long-term survival. However,
only in men were the results of exercise testing able to identify
a high risk subset in whom operation was justified. Although
reduced exercise capacity and ST segment depression corre-
lated with reduced survival in our study, these factors were not
independently predictive of adverse outcome.
Despite the diagnostic limitations of exercise stress myocar-
dial perfusion imaging in women, patients with three-vessel or
left main CAD may be accurately identified using this tech-
nique (23). Several recent studies have indicated that the
ability of myocardial perfusion imaging to identify women with
high risk coronary anatomy is paralleled by ability to predict
subjects liable to have cardiac complications during follow-up.
In a study of 80 women followed up over 2 years, among whom
the cardiac event rate was 1.3%/year, the predictive value of
negative dobutamine–atropine stress results combined with
technetium 99m-sestamibi tomography was high (25). In 212
women with normal LV function studied by Pancholy et al.
(26), age and large myocardial perfusion abnormalities were
independent predictors of death and myocardial infarction. A
recent study by Hachamovitch et al. (27) showed that the value
of perfusion imaging incremental to clinical and exercise
testing data was greater in women than men.
Use of exercise echocardiography for prognostic evalua-
tion. The prognostic implications of exercise echocardiogra-
phy in populations of mixed (predominantly male) gender have
been demonstrated in previous studies. This test is effective for
determining prognosis in patients with chest pain syndromes
(28) and after myocardial infarction (29). However, no study to
date has examined the prognostic utility of exercise echocar-
diography in a large group of women.
The ability of exercise echocardiography to predict future
cardiac events in women might be different than in men for
several reasons: 1) From a clinical standpoint, women with
CAD present at an older age, have a higher incidence of
diabetes, have less extensive coronary disease and have a worse
postinfarction outcome than men (30). Each of these clinical
variables has obvious prognostic implications. Also, there are
differences in exercise physiology and the cardiac response to
exercise between women and men. Women generally have a
lower exercise capacity and are more likely to have a submaxi-
mal heart rate response than men, which may adversely affect
the accuracy of exercise echocardiography (18,31). Moreover,
although the interpretation of this test is dependent on analysis
of regional as well as global LV function, an abnormal ejection
fraction response to exercise is a less reliable indicator of CAD
in women than men (32). Nonetheless, the current study
confirms the independent and incremental prognostic value of
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exercise echocardiography in a large heterogeneous group of
women.
Study limitations. Some limitations are inherent in this
study. The report is potentially biased by involving patients at
a tertiary referral center. However, appropriate training has
been shown (33) to optimize the accuracy of observers, thus
enhancing the applicability of these data in other circum-
stances.
Women who had revascularization performed within 3
months of exercise echocardiography were excluded because
the test may have influenced this outcome. However, although
inclusion of early revascularization as an end point would have
unfairly improved the positive predictive value of the test, their
exclusion probably reduced the complication rate in women
with positive test results. Moreover, women with chest pain
syndromes generally have a more benign prognosis than men—
attested to in this study by an event rate of only 7% (n 5 36)
in the 480 women who did not have primary revascularization
or non–cardiac-related death. For this reason, a larger number
of women will be necessary to show the utility of the test in the
prediction of cardiac-related death.
Conclusions. Exercise echocardiography offers valuable
prognostic information for defining high risk groups of women
with chest pain syndromes. This test may offer important
information to help the physician distinguish those women who
require further expensive diagnostic and therapeutic therapies
from those patients who can be treated more conservatively.
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